Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/jRCT1080224498
jRCT1080224498CompletedPhase 2

A clinical study of CL2020 in patients with epidermolysis bullosa

Life Science Institute, Inc.1 site5 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
5
Locations
1
Primary Endpoint
-
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Intervention Model
Open label, non-randomized
Primary Purpose
Treatment Purpose

Eligibility Criteria

Ages
12age old over to 75age old under (—)
Sex
All

Inclusion Criteria

  • •Major inclusion criteria
  • •Patients with epidermolysis bullosa who have any intractable ulcers
  • •Patients aged 12 to 75 years
  • •Female or male patients

Exclusion Criteria

  • •Major exclusion criteria
  • •Patients with any existing or previous malignant tumor
  • •Female patients who are or may be pregnant or who are breastfeeding

Outcomes

Primary Outcomes

-

safety Safety after infusion of CL2020

Secondary Outcomes

No secondary outcomes reported

Investigators

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Clinical study of CL2020 in patients with acute respiratory distress syndrome associated with SARS-CoV-2 infection (Clinical study of CL2020 in patients with acute respiratory distress syndrome associated with SARS-CoV-2 infection)
jRCT2043210005Life Science Institute, Inc.43
Completed
Phase 1
Clinical study of CL2020 in patients with acute respiratory distress syndrome associated with SARS-CoV-2 infectio
JPRN-jRCT2043210005Fukushima Tatsunobu43
Recruiting
Not Applicable
combined Nd:YAG laser and PRP injection for treatment of periorbital wrinklesSkin and Connective Tissue Diseasesperiorbital wrinkles
PACTR201806003306192Faculty of Medicine for Girls, Al-Azhar University105
Completed
Phase 2
A clinical study of CL2020 in patients with spinal cord injuryspinal cord injury
jRCT1080224764Life Science Institute Inc.10
Completed
Phase 2
A clinical study of CL2020 in patients with spinal cord injuryspinal cord injury
JPRN-jRCT1080224764ife Science Institute Inc.10